Here are three things to know:
1. The privately-held company recently received FDA 510(k) clearance for its Voyant System, a sterile single-use, disposable retractor device with integrated visualization technology for MIS.
2. In 2017, Viseon Spine received $5 million in a series-A financing round.
3. Jeffrey Valko serves as the company’s president and CEO. He has more than 25 years of medical device industry experience.
More articles on devices:
Medacta appoints general manager of U.S. spine division: 3 insights
Medtronic, DePuy Synthes & more: 11 device company launches, releases
5 things to know about NuVasive’s new CEO J. Christopher Barry
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
